An observational study in Breast Cancer, Metastatic Breast Cancer and Radiation Therapy Complication, sponsored by Samsung Medical Center. Recruiting at 1 site in South Korea. Open to female participants aged 19 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-06-29.
Sponsored by Samsung Medical Center · Observational
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's planned enrollment of 400 is above the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Samsung Medical Center is the lead sponsor of 980 studies on the registry; 146 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women treated with hypofractionated RT using IMRT, SBRT, or proton therapy for metastatic breast cancer
Exclusion Criteria:
Local control rate
LC after radiation therapy
Time frame: 1-year
Overall survival rate
Time frame: 1-year
Disease-free survival
disease-free survival rate after the time of RT
Time frame: 1-year
Treatment-related toxicities
Acute and chronic radiation toxicities according to CTCAE v5.0
Time frame: 1-year
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samsung Medical Center